Summary. Neuromodulation of sacral roots provides an alternative mode of therapy for patients presenting with voiding dysfunctions and chronic pelvic pain. Physiologically, this is accomplished by intervention in the neuronal pathways of micturition via sacral nerve-root electrical stimulation. Preoperative evaluation using temporary percutaneous sacral root stimulation selects the patients who are most likely to benefit from permanent electrode implantation. To date, no evidence of peripheral nerve damage has been recorded. Our experience with > 1500 percutaneous tests and 150 permanent foramen implant procedures documents the safety and efficacy of this technique.Neuromodulation of sacral roots provides an alternative mode of therapy for patients presenting with voiding dysfunctions and chronic pelvic pain. Neurostimulation techniques were first applied in the 1960s. A clinical program was initiated by the Urology Department of the University of California at San Francisco (UCSF) in 1981, following an extensive laboratory program [2-4, 12, 13]. Since that time, experience has been gathered in the evaluation, surgery, and follow-up of patients presenting with voiding dysfunction and pelvic pain who have been treated with sacral root electrode implants [7][8][9][10][11]. Urinary urgency, frequency, intermittence, and incontinence as well as burning sensations in the urethra or perineum can be effectively treated with neuromodulation in a high percentage of patients. The goal of such treatment is to relieve the symptoms by retraining the patient's micturition habits.Physiologically, this is accomplished by intervention in the neuronal pathways of micturition [5]. Our hypothesis of the neural modulation mechanism is that the stimulation of A0-myelinated fibers (typically, sacral roots $3 and $4) decreases the spastic behavior of the pelvic floor * To whom correspondence should be addressed and enhances the tone of the urethral sphincter. The threshold for the somatic component of the spinal nerve that innervates the pelvic floor is lower than that for the autonomic component to the bladder; thus, a simultaneous bladder contraction is avoided during stimulation. In many subjects, the primary voiding dysfunction appears to begin with unstable urethral activity, which activates the voiding reflexes, leading to detrusor instability and the associated urgency, frequency, and incontinence. The inhibitory effect of the enhanced urethral sphincter tone suppresses detrusor instability and stabilizes detrusor activity. In the case of chronic pelvic pain, neuromodulation lessens the perceived intensity of the pain by exciting antinociceptive neuronal systems and masking or changing the nature of the pain through the sensation of the electrical stimulation [6].Ideal candidates for neuromodulation are symptomatic patients presenting with urinary urgency, frequency, and incontinence and/or pelvic pain. Neither patients who have failed numerous other therapies such as urethral dilatation, intravesical hydrodilation, and installa...